Luc Truyen
Chief Tech/Sci/R&D Officer en ARGENX SE .
Fortuna: 644 878 $ al 31/03/2024
Perfil
Luc Truyen is currently the Chief Medical Officer at argenx SE.
Previously, he held positions as the Head of Research & Development at Johnson & Johnson Pharmaceutical Group and as the Chief Marketing Officer & Head of R&D at Janssen Alzheimer Immunotherapy.
Dr. Truyen obtained a doctorate degree from the University of Antwerp.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARGEN-X SE
0.00% | 20/02/2024 | 1 631 ( 0.00% ) | 644 878 $ | 31/03/2024 |
Cargos activos de Luc Truyen
| Empresas | Cargo | Inicio |
|---|---|---|
| ARGENX SE | Chief Tech/Sci/R&D Officer | 01/04/2022 |
Antiguos cargos conocidos de Luc Truyen.
| Empresas | Cargo | Fin |
|---|---|---|
| Johnson & Johnson Pharmaceutical Group | Chief Tech/Sci/R&D Officer | - |
| Janssen Alzheimer Immunotherapy | Sales & Marketing | - |
Formación de Luc Truyen.
| University of Antwerp | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Empresas privadas | 2 |
|---|---|
| Johnson & Johnson Pharmaceutical Group | |
| Janssen Alzheimer Immunotherapy |
- Bolsa de valores
- Insiders
- Luc Truyen
